From: Breaking new ground: challenging existing asthma guidelines
Hierarchy of levels of evidence from published papers | |
   1++ | High quality meta-analyses, systematic reviews of randomized controlled trials (RCTs), or RCTs with a very low risk of bias |
   1+ | Well conducted meta-analyses, systematic reviews of RCTs, or RCTs with a low risk of bias |
   1- | Meta-analyses, systematic reviews of RCTs, or RCTs with a high risk of bias |
   2++ | High quality systematic reviews of case control or cohort studies |
 | High quality case control or cohort studies with a very low risk of confounding, bias, or chance and a high probability that the relationship is causal |
   2+ | Well conducted case control or cohort studies with a low risk of confounding, bias, or chance and a moderate probability that the relationship is causal |
   2- | Case control or cohort studies with a high risk of confounding, bias, or chance and a significant risk that the relationship is not causal |
   3 | Non-analytic studies, eg, case reports, case series |
   4 | Expert opinion |
Grades of recommendation | |
   A | At least one meta-analysis, systematic review, or RCT rated as 1++ and directly applicable to the target population, or |
 | A systematic review of RCTs or a body of evidence consisting principally of studies rated as 1+, directly applicable to the target population and demonstrating overall consistency of results |
   B | A body of evidence including studies rated as 2++, directly applicable to the target population and demonstrating overall consistency of results, or |
 | Extrapolated evidence from studies rated as 1++ or 1+ |
   C | A body of evidence including studies rated as 2+, directly applicable to the target population and demonstrating overall consistency of results, or |
 | Extrapolated evidence from studies rated as 2++ |
   D | Evidence level 3 or 4, or |
 | Extrapolated evidence from studies rated as 2+ |